Skip to main content
. Author manuscript; available in PMC: 2015 Jun 5.
Published in final edited form as: Vaccine. 2014 Apr 29;32(27):3341–3344. doi: 10.1016/j.vaccine.2014.04.049

Table 2.

Final Age-adjusted Multivariate Model for Risk of Progression to AIDS or Death Among Those with Non-anergic DTH Test Results

Characteristic HR (95% CI) P
CD4 count category (cells/uL)
 <200 9.10 (4.66 – 17.75) <0.001
 200–499 2.11 (1.20 – 3.71) 0.01
 ≥500 Referent
HIV VL category (copies/mL)
 ≤400 0.13 (0.03 – 0.55) <0.01
 >400 0.66 (0.33 – 1.35) 0.26
 Unknown Referent
Number of Vaccinations
 1–2 1.70 (1.07 – 2.69) 0.02
 ≥ 3 Referent
HBV Vaccine Response
 Anti-HBs <10 IU/L 1.81 (1.03 – 3.19) 0.04
 Anti-HBs ≥10 IU/L Referent

DTH, delayed-type hypersensitivity; HR, hazard ratio; CI, confidence interval; VL, viral load; HBV, hepatitis B virus; anti-HBs, antibody to HBV surface antigen

Gender, year of vaccination, and receiving ART at vaccination, were all not significantly associated with AIDS or death risk in preliminary models